Utkarsh Small Finance Bank has refiled preliminary papers with capital market regulator Sebi and reduced its initial public offering (IPO) size to Rs 500 crore from Rs 1,350 crore planned earlier. Get more Markets News and Business News on Zee Business.
Five such companies which have firmed up their initial public offering (IPO) plans are Glenmark Lifesciences, a fully-owned arm of Glenmark Pharmaceuticals, the city-based bulk drugs firm Supriya Lifesciences, drug formulations firm Windlass Biotech, Bain Capital-backed Emcure Pharma and CX Partners-funded Veeda Clinical Research. According to investment-bankers, they are planning to mop up over Rs 7,000 crore in primary share sales.